TSS
FOLD

Two Sigma Securities’s Amicus Therapeutics FOLD Stock Holding History

Two Sigma Securities’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-16,200
Closed -$220K – 2190
2019
Q1 		$220K Buy
+16,200
New +$198K ﹤0.01% 1415

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Two Sigma Securities's FOLD Position: Q2 2026 in Review

Two Sigma Securities sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 11,955 shares — an estimated $173K sold.

Two Sigma Securities first reported a position in FOLD in Q2 2017 and held it in 6 quarters. The position peaked at $173K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Two Sigma Securities reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 11,955 Amicus Therapeutics shares in Q2 2026, an estimated $173K.
  • Two Sigma Securities first reported a position in Amicus Therapeutics in Q2 2017 and held it in 6 quarters.
  • Two Sigma Securities's Amicus Therapeutics position peaked at $173K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.